// App-Quantinova.ai

POS09 : 4-year clinical outcome of everolimus-eluting vs. sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV trial)

Researchers

Presenter

  • Maeng M

Principal Investigators

  • Olesen K.K.W

  • Christiansen E.H

  • Krusell L.R

  • Kaltoft A

  • Ravkilde J

  • Thayssen P

  • Jensen L.O

Medical Centers

  • Aarhus University Hospital, Aarhus, Denmark

  • Odense University Hospital, Odense, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved